1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Quest PharmaTech Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer Carboplatin, Paclitaxel, oregovomab - Ovarian Neoplasms | Phase 2 | Completed | Quest PharmaTech Inc. | 97 | 2012-06-15 | 2020-09-14 |
Adenocarcinoma (1) · Neoplasms (1) · Ovarian Neoplasms (1)
Carboplatin (1) · Paclitaxel (1) · oregovomab (1)
United States (1)
Christopher Nicodemus, MD FACP (1) · Thomas Woo, M.Sc. (1)